I. Gouin-Thibault

发表

Laboratory Diagnosis of the Thrombophilic State in Cancer Patients

M. Samama, I. Gouin-Thibault, M. Samama, 1999, Seminars in thrombosis and hemostasis.

Improving Anticoagulation Control in Hospitalized Elderly Patients on Warfarin

J. Golmard, J. Cambus, I. Gouin-Thibault, 2010, Journal of the American Geriatrics Society.

Peri-procedural management of dabigatran and rivaroxaban: Duration of anticoagulant discontinuation and drug concentrations.

J. Golmard, Anne-Céline Martin, I. Gouin-Thibault, 2015, Thrombosis research.

[Management of direct oral anticoagulants for invasive procedures].

P. Albaladéjo, I. Gouin-Thibault, N. Rosencher, 2015, Journal des maladies vasculaires.

Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: thrombin or factor-Xa inhibitors. Recommendations of the Working Group on Perioperative Haemostasis and the French Study Group on Thrombosis and Haemostasis.

C. Samama, P. Albaladéjo, T. Lecompte, 2011, Archives of cardiovascular diseases.

Platelet-derived sCD40L: specific inflammatory marker for early-stage severe acute respiratory syndrome coronavirus 2 infection

F. Cognasse, P. Mismetti, I. Gouin-Thibault, 2021, Virology journal.

Probable regulation of factor VIIa–tissue factor and prothrombinase by factor Xa–TFPI and TFPI in vivo

F. Ofosu, S. Craven, I. Gouin-Thibault, 1996, British journal of haematology.

Measurement of factor Xa‐antithrombin III in plasma: relationship to prothrombin activation in vivo

F. Ofosu, I. Gouin-Thibault, L. Dewar, 1995, British journal of haematology.

Induced forms of α2-macroglobulin neutralize heparin and direct oral anticoagulant effects.

C. Samama, S. Pasquali, I. Gouin-Thibault, 2021, International journal of biological macromolecules.

Coagulation Characterization of Prothrombin 20209C > T Variant: About 27 New Cases

M. Fontenay, I. Gouin-Thibault, O. Kosmider, 2020, Thrombosis and Haemostasis.

Study of thrombin generation with St Genesia to evaluate xaban pharmacodynamics: Analytical performances over 18 months

T. Lecompte, I. Gouin-Thibault, V. Siguret, 2020, International journal of laboratory hematology.

Rivaroxaban pharmacodynamics in healthy volunteers evaluated with thrombin generation and the active protein C system: Modeling and assessing interindividual variability

M. Loriot, C. Funck-Brentano, J. Salem, 2019, Journal of thrombosis and haemostasis : JTH.

Reply to: thrombin generation tests and viscoelastic testing in cirrhosis: comparing apples and oranges?

C. Samama, C. Lentschener, I. Gouin-Thibault, 2017, European journal of anaesthesiology.

Assessment of haemostasis in patients with cirrhosis: Relevance of the ROTEM tests? A prospective, cross-sectional study

C. Samama, P. Sogni, C. Lentschener, 2016, European journal of anaesthesiology.

[Non-VKA oral anticoagulants: an update for the clinical biologists].

J. Dogné, M. Samama, I. Gouin-Thibault, 2015, Annales de biologie clinique.

Modified ROTEM for the detection of rivaroxaban and apixaban anticoagulant activity in whole blood: A diagnostic test study

C. Samama, J. Golmard, I. Gouin-Thibault, 2019, European journal of anaesthesiology.

Interindividual variability in dabigatran and rivaroxaban exposure: contribution of ABCB1 genetic polymorphisms and interaction with clarithromycin

M. Loriot, P. Beaune, C. Funck-Brentano, 2017, Journal of thrombosis and haemostasis : JTH.

FXa-α2-Macroglobulin Complex Neutralizes Direct Oral Anticoagulants Targeting FXa In Vitro and In Vivo

I. Gouin-Thibault, P. Gaussem, V. Siguret, 2018, Thrombosis and Haemostasis.

Multimodal assessment of non‐specific hemostatic agents for apixaban reversal

C. Samama, I. Gouin-Thibault, A. Godier, 2015, Journal of thrombosis and haemostasis : JTH.

Markers of activated coagulation in patients with factor V Leiden and/or G20210A prothrombin gene mutation.

M. Samama, I. Gouin-Thibault, I. Elalamy, 2002, Thrombosis research.

New Data on the Pharmacology of Heparin and Low Molecular Weight Heparins

M. Samama, I. Gouin-Thibault, L. Bara, 2012, Drugs.

The effectiveness of platelet supplementation for the reversal of ticagrelor-induced inhibition of platelet aggregation: An in-vitro study

C. Samama, Anne-Céline Martin, I. Gouin-Thibault, 2016, European journal of anaesthesiology.

Elderly Medical Patients Treated with Prophylactic Dosages of Enoxaparin

I. Gouin-Thibault, L. Drouet, É. Pautas, 2007, Drugs & aging.

Is Modification of Diet in Renal Disease formula similar to Cockcroft-Gault formula to assess renal function in elderly hospitalized patients treated with low-molecular-weight heparin?

J. Golmard, I. Gouin-Thibault, É. Pautas, 2007, The journals of gerontology. Series A, Biological sciences and medical sciences.

International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants

S. Kitchen, E. Favaloro, I. Gouin-Thibault, 2018, Thrombosis and Haemostasis.

Safety Profile of Different Low-Molecular Weight Heparins Used at Therapeutic Dose

I. Gouin-Thibault, É. Pautas, V. Siguret, 2005, Drug safety.

Predictors of pre-procedural concentrations of direct oral anticoagulants: a prospective multicentre study

J. Golmard, Anne-Céline Martin, I. Gouin-Thibault, 2017, European heart journal.

Assessment of apixaban plasma levels by laboratory tests: suitability of three anti-Xa assays

S. Laporte, T. Lecompte, I. Gouin-Thibault, 2013, Thrombosis and Haemostasis.

Comparative Analysis of a French Prospective Series of 144 Patients with Heparin-Induced Thrombocytopenia (FRIGTIH) and the Literature

B. Giraudeau, V. Gouilleux-Gruart, E. de Raucourt, 2020, Thrombosis and Haemostasis.

Reversal of overanticoagulation in very elderly hospitalized patients with an INR above 5.0: 24-hour INR response after vitamin K administration.

J. Golmard, I. Gouin-Thibault, É. Pautas, 2011, The American journal of medicine.

Haemorrhagic Complications of Vitamin K Antagonists in the Elderly

I. Gouin-Thibault, P. Gaussem, É. Pautas, 2006, Drugs & aging.

Potential usefulness of activated charcoal (DOAC remove®) for dRVVT testing in patients receiving Direct Oral AntiCoagulants.

I. Gouin-Thibault, P. Gaussem, V. Siguret, 2019, Thrombosis research.

Vitamin K antagonist use in the elderly: special considerations.

I. Gouin-Thibault, É. Pautas, V. Siguret, 2007, Future cardiology.

Warfarin therapy: influence of pharmacogenetic and environmental factors on the anticoagulant response to warfarin.

I. Gouin-Thibault, É. Pautas, V. Siguret, 2008, Vitamins and hormones.

Anticoagulation therapy in France: state-of-the-art in 2020

Y. Gruel, P. Albaladéjo, I. Gouin-Thibault, 2020 .

P-glycoprotein influences urinary excretion of aldosterone in healthy individuals.

M. Loriot, C. Funck-Brentano, J. Salem, 2019, Journal of hypertension.

Periprocedural management of anticoagulation for atrial fibrillation catheter ablation in direct oral anticoagulant–treated patients

Anne-Céline Martin, I. Gouin-Thibault, A. Godier, 2018, Clinical cardiology.

[Relationship between maintenance dosages of fluindione (Préviscan) and warfarin (Coumadin) for patients 70 years and older].

J. Golmard, I. Gouin-Thibault, É. Pautas, 2015, La Revue de medecine interne.

Bleeding and thrombotic events in patients with severe COVID-19 supported with extracorporeal membrane oxygenation: a nationwide cohort study

P. Demondion, P. Leprince, E. Fadel, 2022, Intensive Care Medicine.

Anemia in the elderly: usefulness of an easy and comprehensive laboratory screen.

J. Golmard, I. Gouin-Thibault, É. Pautas, 2012, Annales de biologie clinique.

Prevalence of Hereditary Thrombophilia in Patients Older Than 75 Years With Venous Thromboembolism Referred for Thrombophilia Screening.

J. Golmard, J. Emmerich, I. Gouin-Thibault, 2015, The journals of gerontology. Series A, Biological sciences and medical sciences.

A need for evidence-based clinical practice guidelines for the use of heparins in the elderly

I. Gouin-Thibault, É. Pautas, V. Siguret, 2010, Clinical interventions in aging.

Heparin Anti-Xa Activity, a Readily Available Unique Test to Quantify Apixaban, Rivaroxaban, Fondaparinux, and Danaparoid Levels.

B. Rozec, I. Gouin-Thibault, C. Ternisien, 2020, Anesthesia and analgesia.

Updated French practical guidelines on the management of dabigatran-treated patients.

J. Gris, I. Gouin-Thibault, 2018, Anaesthesia, critical care & pain medicine.

Evaluation of dabigatran, rivaroxaban and apixaban target-specific assays in a multicenter French study.

J. Golmard, S. Susen, Y. Gruel, 2017, Thrombosis research.

Overanticoagulation with coumarin and cutaneous azole therapy.

M. Loriot, I. Gouin-Thibault, É. Pautas, 2008, Annals of internal medicine.

[Divisibility of warfarin and fluindione tablets tested in elderly patients and their family circle].

J. Golmard, I. Gouin-Thibault, É. Pautas, 2011, Geriatrie et psychologie neuropsychiatrie du vieillissement.

Platelet Functions During Extracorporeal Membrane Oxygenation. Platelet–Leukocyte Aggregates Analyzed by Flow Cytometry as a Promising Tool to Monitor Platelet Activation

I. Gouin-Thibault, P. Gaussem, E. Flécher, 2020, Journal of clinical medicine.

Impact of High-Dose Prophylactic Anticoagulation in Critically Ill Patients With COVID-19 Pneumonia

P. Morange, S. Susen, S. Laporte, 2021, Chest.

Is the thrombopoietin assay useful for differential diagnosis of thrombocytopenia? Analysis of a cohort of 160 patients with thrombocytopenia and defined platelet life span.

C. Chomienne, I. Gouin-Thibault, B. Cassinat, 2001, Clinical chemistry.

No accumulation of the peak anti‐factor Xa activity of tinzaparin in elderly patients with moderate‐to‐severe renal impairment: the IRIS substudy

A. Leizorovicz, I. Gouin-Thibault, É. Pautas, 2011, Journal of thrombosis and haemostasis : JTH.

Apixaban and rivaroxaban in obese patients treated for venous thromboembolism: Drug levels and clinical outcomes.

G. Mahé, I. Gouin-Thibault, C. Rousseau, 2021, Thrombosis research.

In vitro interaction of the pentasaccharide idraparinux (SanOrg 34006) with unfractionated heparin

F. Maris, M. Samama, I. Gouin-Thibault, 2003, Journal of thrombosis and haemostasis : JTH.

Ticagrelor reversal: in vitro assessment of four haemostatic agents

Anne-Céline Martin, I. Gouin-Thibault, A. Godier, 2017, Journal of Clinical Pathology.

Concentrations of direct oral anticoagulants according to guidelines for the periprocedural management of low bleeding risk procedures.

Anne-Céline Martin, I. Gouin-Thibault, A. Godier, 2020, Anaesthesia, critical care & pain medicine.

Management of a High-Risk Surgery with Emicizumab and Factor VIII in a Child with a Severe Hemophilia A and Inhibitor

B. Guillet, I. Gouin-Thibault, B. Fraisse, 2021, TH open : companion journal to thrombosis and haemostasis.

A model predicting fluindione dose requirement in elderly inpatients including genotypes, body weight, and amiodarone

M. Loriot, J. Golmard, C. Moreau, 2013, Thrombosis and Haemostasis.

Genetic Factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) Are Predictor Variables for Warfarin Response in Very Elderly, Frail Inpatients

M. Loriot, P. Beaune, J. Golmard, 2010, Clinical pharmacology and therapeutics.

Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory

G. Lippi, R. Medcalf, J. Dogné, 2020, Thrombosis Journal.

Combined Platelet and Erythrocyte Salvage: Evaluation of a New Filtration-based Autotransfusion Device

N. Nesseler, I. Gouin-Thibault, P. Gaussem, 2021, Anesthesiology.

The Thrombophilic State in Cancer Patients

M. Samama, I. Gouin-Thibault, A. Achkar, 2001, Acta Haematologica.

Assessment of DOAC in GEriatrics ( Adage Study): Rivaroxaban/Apixaban Concentrations and Thrombin Generation Profiles in NVAF Very Elderly Patients

E. Puymirat, I. Gouin-Thibault, P. Gaussem, 2022, Thrombosis and Haemostasis.

Thrombosis and Haemostasis Assessment of DOAC in GEriatrics (ADAGE study): rivaroxaban/apixaban concentrations and thrombin generation profiles in NVAF very elderly patients academic prospective exploratory multicenter study

E. Puymirat, I. Gouin-Thibault, P. Gaussem, 2022 .

2021 Update of the International Council for Standardization in Haematology Recommendations for Laboratory Measurement of Direct Oral Anticoagulants

S. Kitchen, E. Favaloro, I. Gouin-Thibault, 2021, Thrombosis and Haemostasis.

Intravenous thrombolysis for acute ischaemic stroke in patients on direct oral anticoagulants

S. Susen, Y. Gruel, E. Touzé, 2018, European journal of neurology.

P2Y12 Inhibition beyond Thrombosis: Effects on Inflammation

N. Nesseler, I. Gouin-Thibault, P. Gaussem, 2020, International journal of molecular sciences.

Impact of age on in vitro metabolism of clopidogrel: a potential explanation for high on-treatment platelet reactivity in the elderly?

I. Gouin-Thibault, P. Gaussem, C. Bachelot-Loza, 2022, Research and practice in thrombosis and haemostasis.

Management of Gastrointestinal Bleeding and Resumption of Oral Anticoagulant Therapy in Patients with Atrial Fibrillation: A Multidisciplinary Discussion

R. Benamouzig, Jeannot Schmidt, Anne-Céline Martin, 2023, American Journal of Cardiovascular Drugs.

PT, aPTT, TT and the hemostatic safety threshold of dabigatran and rivaroxaban.

I. Gouin-Thibault, M. Horellou, É. Mazoyer, 2016, Annales de biologie clinique.

[Surgery and invasive procedures in patients on long-term treatment with oral direct thrombin or factor Xa inhibitors].

C. Samama, P. Linden, P. Albaladéjo, 2011, Annales francaises d'anesthesie et de reanimation.

GFHT Proposals On The Practical Use Of Argatroban - With Specifics Regarding Vaccine-Induced Immune Thrombotic Thrombocytopaenia (VITT).

Y. Béjot, C. Frère, Y. Gruel, 2021, Anaesthesia, critical care & pain medicine.

Optimizing the Use of Anticoagulants (Heparins and Oral Anticoagulants) in the Elderly

I. Gouin-Thibault, P. Gaussem, É. Pautas, 2013, Drugs & Aging.

Predicting the warfarin maintenance dose in elderly inpatients at treatment initiation: accuracy of dosing algorithms incorporating or not VKORC1/CYP2C9 genotypes

M. Loriot, J. Golmard, C. Moreau, 2011, Journal of thrombosis and haemostasis : JTH.

Association rate constants rationalise the pharmacodynamics of apixaban and rivaroxaban

C. Samama, J. Golmard, Anne-Céline Martin, 2015, Thrombosis and Haemostasis.

Transferability of Published Population Pharmacokinetic Models for Apixaban and Rivaroxaban to Subjects with Obesity Treated for Venous Thromboembolism: A Systematic Review and External Evaluations

E. Ollier, I. Gouin-Thibault, K. Lacut, 2023, Pharmaceutics.

Heparin‐releasable TFPI is not depleted after repeated injections of tinzaparin at therapeutic dose for up to 30 days

F. Depasse, I. Gouin-Thibault, É. Pautas, 2003, Journal of thrombosis and haemostasis : JTH.

Low Levels of Protein S Activity in Factor V Depleted Plasma Used in APC Resistance Test

J. Amiral, I. Gouin-Thibault, J. Conard, 1998, Thrombosis and Haemostasis.

[Elderly patients with myelodysplastic syndrome with del 5q receiving lenalidomide: two case reports with poor prognosis].

I. Gouin-Thibault, V. Siguret, C. Bilhou-Nabera, 2010, Annales de biologie clinique.

Studies on hemostasis in COVID‐19 deserve careful reporting of the laboratory methods, their significance, and their limitations

P. Fontana, T. Lecompte, I. Gouin-Thibault, 2020, Journal of Thrombosis and Haemostasis.

Unusual expression of the F9 gene in peripheral lymphocytes hinders investigation of F9 mRNA in hemophilia B patients

G. Agnelli, I. Gouin-Thibault, D. Imberti, 2003, Journal of thrombosis and haemostasis : JTH.

Heparin‐induced thrombocytopenia leading to a diagnosis of essential thrombocythemia

P. Mabo, I. Gouin-Thibault, P. Guéret, 2021, International journal of laboratory hematology.

Vitamin K antagonist use in the elderly: special considerations.

I. Gouin-Thibault, É. Pautas, V. Siguret, 2007, Future cardiology.